Mink Therapeutics Inc
NASDAQ:INKT
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Mink Therapeutics Inc
NASDAQ:INKT
|
US |
|
MatsukiyoCocokara & Co
TSE:3088
|
JP |
|
Montrose Environmental Group Inc
NYSE:MEG
|
US |
|
L
|
LVMH Moet Hennessy Louis Vuitton SE
XHAM:MOH
|
FR |
|
R
|
Rojana Industrial Park PCL
SET:ROJNA
|
TH |
|
EDA Group Holdings Ltd
HKEX:2505
|
CN |
|
Gimv NV
XBRU:GIMB
|
BE |
|
Tempur Sealy International Inc
NYSE:TPX
|
US |
|
CONSOL Energy Inc
NYSE:CEIX
|
US |
|
T
|
Truist Financial Corp
SWB:BBK
|
US |
|
M
|
MacroAsia Corp
XPHS:MAC
|
PH |
|
Unity Software Inc
NYSE:U
|
US |
|
SMCP SA
PAR:SMCP
|
FR |
|
Mckesson Corp
NYSE:MCK
|
US |
|
Taylor Devices Inc
NASDAQ:TAYD
|
US |
Bankruptcy Probability
Mink Therapeutics Inc's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Mink Therapeutics Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| US |
|
Mink Therapeutics Inc
NASDAQ:INKT
|
57.4m USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
384.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
181.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
167B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
113.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
65B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
44.3B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
|
40.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Mink Therapeutics Inc's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Mink Therapeutics Inc has total debt of 5.2m USD. This includes both short-term (5.2m USD) and long-term (0 USD) debt.
You can find a full breakdown on its Balance Sheet.
